This double-blind cross-over trial (n=24) investigates the effect of repeated doses of psilocybin (2x) at varying doses of psilocybin (1 or 10mg) on concussion headache.
Compound Psilocybin
Country United States of America
Visit trial
Trial Details
Trial Number
Sponsors & Collaborators
Yale UniversityThe Yale Psychedelic Science Group was established in 2016.